Dimple Modi
Senior Director. Oncology Precision Medicine Regeneron Pharmaceuticals
Dimple Modi is Senior Director, Oncology Precision Medicine at Regeneron, a role held since January 2026, having joined in 2022 as Director. Previously, Dimple spent six years at AbbVie as a Senior Scientist in Oncology Precision Medicine (Clinical Biomarkers).
Seminars
Thursday 18th March 2027
Panel Discussion: Acting on Molecular Progression to Improve Therapeutic Decision Making Before Imaging Detects Resistance
9:30 am
- Determining how much molecular change justifies a switch when the scan still reads stable
- Weighing the risk of switching too early against the cost of waiting for radiographic confirmation
- Establishing what evidence oncologists and payers need before molecular progression becomes an accepted trigger
Friday 19th March 2027
Panel Discussion: Harnessing Multimodal Technologies to Improve Patient Profiling for Increased Accuracy in Diagnostics
9:30 am
- Integrating protein, methylation and fragmentomic signal to resolve cases that genomic profiling alone leaves ambiguous
- Determining which analyte combinations improve accuracy enough to justify the added cost and complexity
- Embedding multi-omic workflows into patient selection and diagnostic paradigms
